Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LORI SPERBER

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Pediatrics

NPI
1043711062
CMS profile
10742032
Location
NEW YORK, NY

General Payments · PY2021–2024

$1,080.04

  • Reported across 52 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$282.75

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $282.75 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Neurelis, Inc. $173.53 11
Supernus Pharmaceuticals, Inc. $65.27 3
Neos Therapeutics, LP $43.95 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $73.18 5
PY2022 $364.00 8
PY2023 $360.11 23
PY2024 $282.75 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Neos Therapeutics, LP $22.03 01/30/2024 Food and Beverage Undisputed 01/23/2026 1082663431 CMS
Neos Therapeutics, LP $21.92 04/16/2024 Food and Beverage Undisputed 01/23/2026 1082665617 CMS
Neurelis, Inc. $34.67 01/02/2024 Food and Beverage Undisputed 01/23/2026 1145670978 CMS
Neurelis, Inc. $9.63 01/10/2024 Food and Beverage Undisputed 01/23/2026 1145670980 CMS
Neurelis, Inc. $13.01 02/29/2024 Food and Beverage Undisputed 01/23/2026 1145670982 CMS
Neurelis, Inc. $4.13 03/05/2024 Food and Beverage Undisputed 01/23/2026 1145670984 CMS
Neurelis, Inc. $23.80 04/12/2024 Food and Beverage Undisputed 01/23/2026 1145670986 CMS
Neurelis, Inc. $21.03 09/05/2024 Food and Beverage Undisputed 01/23/2026 1145670988 CMS
Neurelis, Inc. $12.14 10/08/2024 Food and Beverage Undisputed 01/23/2026 1145670990 CMS
Neurelis, Inc. $5.45 10/22/2024 Food and Beverage Undisputed 01/23/2026 1145670992 CMS
Neurelis, Inc. $19.59 11/05/2024 Food and Beverage Undisputed 01/23/2026 1145670994 CMS
Neurelis, Inc. $8.04 12/16/2024 Food and Beverage Undisputed 01/23/2026 1145670996 CMS
Neurelis, Inc. $22.04 12/17/2024 Food and Beverage Undisputed 01/23/2026 1145670998 CMS
Supernus Pharmaceuticals, Inc. $19.02 02/15/2024 Food and Beverage Undisputed 01/23/2026 1147896259 CMS
Supernus Pharmaceuticals, Inc. $20.28 12/09/2024 Food and Beverage Undisputed 01/23/2026 1147787715 CMS
Supernus Pharmaceuticals, Inc. $25.97 12/09/2024 Food and Beverage Undisputed 01/23/2026 1147787717 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.